{'fraction_non_alphanumeric': 0.0421216848673947, 'fraction_numerical': 0.0109204368174727, 'mean_word_length': 5.233009708737864, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Thyroid nodules: clinical management and differential diagnosis].

Thyroid nodules are common and are frequently benign. The prevalence of thyroid nodules ranges from 3-7% (palpation) to 50% (ultrasonography). Thyroid cancer occurs in 5-10% of nodules. Thyroid ultrasonography (US) is not a screening test but all patients with palpable thyroid nodule should undergo US examination. US-guided fine-needle aspiration citology (FNC) is recommendend for nodules with suspicious features at US examination or when clinical risk factors occur. A radioisotope scan is useful if the TSH is low or suppressed to detect (benign) functioning nodules.